About this partner
Cytotheryx is a biomedical research company focused on the development of a consistent, high-quality source of human hepatocytes (HHCs) and the application of those HHCs for multiple research and clinical applications. HHCs are used in toxicology studies, hepatitis research and transplants, but the limited supply restricts these broader applications. Cytotheryx's foundational science will relieve the restriction and enable applications in liver assist devices, cell and gene therapy, drug delivery and allotransplantation.
In the Know: Healthcare News for February 27, 2023
For the Record with John Swart, CEO, Cytotheryx